Conversations powered by KPMG Luxembourg

Web3, or wait and see?

30 min · 16 de jun de 2025
Portada del episodio Web3, or wait and see?

Descripción

In our third episode on digital assets and blockchain, we explore the evolution of Web3: from a speculative concept to a maturing global industry, with a focus on Luxembourg’s emerging role in the space. Our guest, - Maxime Baron, CEO of Hash Consulting - discusses how blockchain technology, once compared to the "floppy disk era", is steadily becoming more user-friendly and mainstream. We break down what Web3 really means, the importance of decentralization, and how regulation can either foster or stifle innovation depending on its execution. From media misconceptions and meme coins to serious infrastructure and financial applications, we examine how blockchain is maturing despite growing pains.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Conversations powered by KPMG Luxembourg!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

10 episodios

episode Where pharma and funds converge | Part 1 artwork

Where pharma and funds converge | Part 1

In Part 1 of this two-episode special of Conversations powered by KPMG Luxembourg, we dive into the converging worlds of the funds industry and pharmaceuticals. Featuring Annick Breton (Partner, Head of Consulting at KPMG Luxembourg), this episode brings together Romain Labbé (Secretary General at the IML), Natasha Deloge (Head of the Innovation Division at the CSSF), Pierre Mottion (Head of DLT and Strategy/Investment Fund Services at Clearstream), and Matthias Van den Eede (Head of Digital Business Development & Beewise at Azimut Investments), as they discuss the common similarities and challenges affecting their industries. Part 1 of this topic delves into the issues surrounding ongoing consumer confidence and how it is affecting the pharmaceutical and investment funds ecosystems.

28 de feb de 202526 min